ERIK LITTLE: Open Payments
NPI 1558464560 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,527 in 127 payments from 32 companies in 2025. Trend: 2023 $2,589 · 2024 $2,372 · 2025 $2,527
Food & beverage: $2,527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $361 |
| Novo Nordisk Inc | 22 | $321 |
| Lilly USA, LLC | 12 | $221 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $173 |
| AstraZeneca Pharmaceuticals LP | 4 | $150 |
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Exact Sciences Corporation | 3 | $76 |
| Janssen Pharmaceuticals, Inc | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 6 | $70 |
Products named: UBRELVY, JARDIANCE, Wegovy, MOUNJARO, FARXIGA, Ozempic, REXULTI, VRAYLAR.
Industry payments across PA — which companies pay providers there.
